The link you have selected will take you away from the TAVNEOS® (avacopan) website to one that is not owned or controlled by ChemoCentryx. ChemoCentryx accepts no responsibility for the content of linked sites.
The link you have selected will take you away from the TAVNEOS® (avacopan) website to the patient support program enrollment website
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click “OK” if you are a healthcare professional.
Based on your location, you are being redirected to the website of our licensee Vifor Fresenius Medical Care Renal Pharma Ltd. CCXI does not have responsibility for, or control of, the contents, availability, operation, or performance of the website.
Wholesale Acquisition Cost, or WAC, and Average Wholesale Prices, or AWP, are representative of prices paid by wholesalers. Prices paid by patients may be higher or lower than WAC or AWP, and depend on patients’ insurance coverage.
WAC and AWP provide information about the relative prices of marketed drugs and other drugs in the same therapeutic className. They do not reflect price per dosage or course of treatment or the cost effectiveness of the product.
This information is intended for authorized prescribers of prescription drugs in Vermont, as required by Vermont’s Pharmaceutical Marketer Price Disclosure law Vermont Law 18 V.S.A. § 4633.
Vermont Disclosure Forms
If you’re considering TAVNEOS for your adult patients, ChemoCentryx provides resources to help them start and stay on therapy.
TAVNEOS can cause serious side effects, including:
Your healthcare provider will do blood tests to check how well your liver is working before starting and during your treatment with TAVNEOS.
including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAVNEOS and certain other medicines may affect each other and cause side effects. Keep a list of the medicines you take and show it to your healthcare provider and pharmacist.
The most common side effects of TAVNEOS include:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active anti-neutrophil cytoplasmic autoantibody(ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA], formerly known as Wegener’s granulomatosis, and microscopic polyangiitis [MPA]).
It is not known if TAVNEOS is safe and effective in children under the age of 18.
TAVNEOS is available as a 10 mg capsule.